Passage Bio, Inc. (PASG) Misses Q3 EPS by 8c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Evolv Technology (EVLV) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
• Freedom Broker Upgrades Alico Inc. (ALCO) to Buy
• Theriva Biologics (TOVX) Misses Q2 EPS by 1c